chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Vaginal haemorrhage
Clinical narrative: Pink spotting; This spontaneous case was reported by a consumer and describes the occurrence of VAGINAL HAEMORRHAGE (Pink spotting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Intrauterine contraception (The patient said that has an IUD and that never had any vaginal bleeding. ) in 2017.    On 18-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jul-2021, the patient experienced VAGINAL HAEMORRHAGE (Pink spotting). At the time of the report, VAGINAL HAEMORRHAGE (Pink spotting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported by reporter. Treatment information was not reported.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Cold sweat, Eye disorder, Headache, Hyperhidrosis, Magnetic resonance imaging
Clinical narrative: sweaty; clammy; blurred vision; His left eye had no peripheral vision; it was like he had spider webs in both eyes; headache; left chest muscle was sore and kind of hurt; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweaty), COLD SWEAT (clammy), VISION BLURRED (blurred vision), VISUAL FIELD DEFECT (His left eye had no peripheral vision) and EYE DISORDER (it was like he had spider webs in both eyes) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No relevant medical history was reported.  Concomitant products included DOXYCYCLINE and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 10-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Aug-2021, the patient experienced HEADACHE (headache) and MYALGIA (left chest muscle was sore and kind of hurt). On 11-Aug-2021, the patient experienced HYPERHIDROSIS (sweaty), COLD SWEAT (clammy), VISION BLURRED (blurred vision), VISUAL FIELD DEFECT (His left eye had no peripheral vision) and EYE DISORDER (it was like he had spider webs in both eyes). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of 1 dosage form. At the time of the report, HYPERHIDROSIS (sweaty), COLD SWEAT (clammy), HEADACHE (headache) and MYALGIA (left chest muscle was sore and kind of hurt) outcome was unknown and VISION BLURRED (blurred vision), VISUAL FIELD DEFECT (His left eye had no peripheral vision) and EYE DISORDER (it was like he had spider webs in both eyes) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Magnetic resonance imaging: normal (normal) found no tumor, brain bleed, stroke, neurological, or cardiac disorder..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient also had an ekg and blood draw and spent about 7 hours in the ER. The emergency room doctor did say that when multiple sclerosis affects vision it lasts for days or weeks.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Vision blurred, Visual field defect
Clinical narrative: sweaty; clammy; blurred vision; His left eye had no peripheral vision; it was like he had spider webs in both eyes; headache; left chest muscle was sore and kind of hurt; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweaty), COLD SWEAT (clammy), VISION BLURRED (blurred vision), VISUAL FIELD DEFECT (His left eye had no peripheral vision) and EYE DISORDER (it was like he had spider webs in both eyes) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No relevant medical history was reported.  Concomitant products included DOXYCYCLINE and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 10-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Aug-2021, the patient experienced HEADACHE (headache) and MYALGIA (left chest muscle was sore and kind of hurt). On 11-Aug-2021, the patient experienced HYPERHIDROSIS (sweaty), COLD SWEAT (clammy), VISION BLURRED (blurred vision), VISUAL FIELD DEFECT (His left eye had no peripheral vision) and EYE DISORDER (it was like he had spider webs in both eyes). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of 1 dosage form. At the time of the report, HYPERHIDROSIS (sweaty), COLD SWEAT (clammy), HEADACHE (headache) and MYALGIA (left chest muscle was sore and kind of hurt) outcome was unknown and VISION BLURRED (blurred vision), VISUAL FIELD DEFECT (His left eye had no peripheral vision) and EYE DISORDER (it was like he had spider webs in both eyes) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Magnetic resonance imaging: normal (normal) found no tumor, brain bleed, stroke, neurological, or cardiac disorder..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient also had an ekg and blood draw and spent about 7 hours in the ER. The emergency room doctor did say that when multiple sclerosis affects vision it lasts for days or weeks.
Sex: U
Vaccine: COVID19
Symptoms: Dizziness, Heart rate, Heart rate increased
Clinical narrative: Extremely dizzy; Heart rate has been in the 90's-140's for the last hour; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Extremely dizzy) and HEART RATE INCREASED (Heart rate has been in the 90's-140's for the last hour) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Extremely dizzy) and HEART RATE INCREASED (Heart rate has been in the 90's-140's for the last hour). At the time of the report, DIZZINESS (Extremely dizzy) and HEART RATE INCREASED (Heart rate has been in the 90's-140's for the last hour) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Heart rate: high (High) The patient's heart rate was 90-140's..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product use was provided by the reporter.   No treatment medications were reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Product dose omission issue
Clinical narrative: really really sick; more than 36 passed since the first dose and she did not get the second; This spontaneous case was reported by an other health care professional and describes the occurrence of ILLNESS (really really sick) and PRODUCT DOSE OMISSION ISSUE (more than 36 passed since the first dose and she did not get the second) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in August 2020.    On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (really really sick) and PRODUCT DOSE OMISSION ISSUE (more than 36 passed since the first dose and she did not get the second). At the time of the report, ILLNESS (really really sick) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (more than 36 passed since the first dose and she did not get the second) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Relevant concomitant medications were not provided. Treatment information was not provided.   This case was linked to MOD-2021-291699 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Headache, Nausea, Pyrexia
Clinical narrative: Fever; Nauseousness; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), NAUSEA (Nauseousness) and HEADACHE (Headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever), NAUSEA (Nauseousness) and HEADACHE (Headache). At the time of the report, PYREXIA (Fever), NAUSEA (Nauseousness) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.  No treatment history was reported.   Reporter did not allow further contact
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Chest discomfort, Gastrooesophageal reflux disease, Headache, Muscle strain
Clinical narrative: has been feeling anxious/very very anxious; has some discomfort in the chest; t's more like a strain, like when you lift something heavy and it strains you in the chest, in the muscle; has some discomfort in the throat; acid reflux; headaches; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (has been feeling anxious/very very anxious), CHEST DISCOMFORT (has some discomfort in the chest), MUSCLE STRAIN (t's more like a strain, like when you lift something heavy and it strains you in the chest, in the muscle), OROPHARYNGEAL DISCOMFORT (has some discomfort in the throat) and GASTROOESOPHAGEAL REFLUX DISEASE (acid reflux) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939676) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Medical history was not provided.  Concomitant products included NEBIVOLOL HYDROCHLORIDE (BYSTOLIC), DULAGLUTIDE (TRULICITY), DULOXETINE HYDROCHLORIDE (CYMBALTA), LEVOTHYROXINE, LOSARTAN, TRAMADOL and TRAZODONE for an unknown indication.   On 19-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Aug-2021, the patient experienced ANXIETY (has been feeling anxious/very very anxious), CHEST DISCOMFORT (has some discomfort in the chest), MUSCLE STRAIN (t's more like a strain, like when you lift something heavy and it strains you in the chest, in the muscle), OROPHARYNGEAL DISCOMFORT (has some discomfort in the throat), GASTROOESOPHAGEAL REFLUX DISEASE (acid reflux) and HEADACHE (headaches). At the time of the report, ANXIETY (has been feeling anxious/very very anxious), CHEST DISCOMFORT (has some discomfort in the chest), MUSCLE STRAIN (t's more like a strain, like when you lift something heavy and it strains you in the chest, in the muscle), OROPHARYNGEAL DISCOMFORT (has some discomfort in the throat), GASTROOESOPHAGEAL REFLUX DISEASE (acid reflux) and HEADACHE (headaches) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No treatment details were provided by reporter.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal discomfort
Clinical narrative: has been feeling anxious/very very anxious; has some discomfort in the chest; t's more like a strain, like when you lift something heavy and it strains you in the chest, in the muscle; has some discomfort in the throat; acid reflux; headaches; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (has been feeling anxious/very very anxious), CHEST DISCOMFORT (has some discomfort in the chest), MUSCLE STRAIN (t's more like a strain, like when you lift something heavy and it strains you in the chest, in the muscle), OROPHARYNGEAL DISCOMFORT (has some discomfort in the throat) and GASTROOESOPHAGEAL REFLUX DISEASE (acid reflux) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939676) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Medical history was not provided.  Concomitant products included NEBIVOLOL HYDROCHLORIDE (BYSTOLIC), DULAGLUTIDE (TRULICITY), DULOXETINE HYDROCHLORIDE (CYMBALTA), LEVOTHYROXINE, LOSARTAN, TRAMADOL and TRAZODONE for an unknown indication.   On 19-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Aug-2021, the patient experienced ANXIETY (has been feeling anxious/very very anxious), CHEST DISCOMFORT (has some discomfort in the chest), MUSCLE STRAIN (t's more like a strain, like when you lift something heavy and it strains you in the chest, in the muscle), OROPHARYNGEAL DISCOMFORT (has some discomfort in the throat), GASTROOESOPHAGEAL REFLUX DISEASE (acid reflux) and HEADACHE (headaches). At the time of the report, ANXIETY (has been feeling anxious/very very anxious), CHEST DISCOMFORT (has some discomfort in the chest), MUSCLE STRAIN (t's more like a strain, like when you lift something heavy and it strains you in the chest, in the muscle), OROPHARYNGEAL DISCOMFORT (has some discomfort in the throat), GASTROOESOPHAGEAL REFLUX DISEASE (acid reflux) and HEADACHE (headaches) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No treatment details were provided by reporter.
Sex: F
Vaccine: COVID19
Symptoms: Off label use
Clinical narrative: Received 3rd dose on an Unknown reason; This spontaneous case was reported by an other health care professional and describes the occurrence of OFF LABEL USE (Received 3rd dose on an Unknown reason) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Osteoporosis.    On 18-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Aug-2021, the patient experienced OFF LABEL USE (Received 3rd dose on an Unknown reason). On 18-Aug-2021, OFF LABEL USE (Received 3rd dose on an Unknown reason) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient prescribed to take PROLEA shots as she took vaccine changed appointment for a PROLEA shot for osteoporosis. No treatment medications were provided by reporter. No concomitant medications were provided by reporter.   Reporter did not allow further contact
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: COVID arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (COVID arm) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 010M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (COVID arm). At the time of the report, VACCINATION COMPLICATION (COVID arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medications included: daily vitamin, anti-histamine and low dose hormone . Patient has taken Benadryl capsules a few days before second dose. Treatment medications was not provided.   Reporter did not allow further contact
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pyrexia, Skin mass, Vaccination site erythema, Vaccination site swelling
Clinical narrative: temperature is 99.9 Fahrenheit  today; moderate left shoulder joint pain; has swelling; bump just a size of a quarter/bump has now grown to 3-4 inches in diameter; slight reddish round bump on the left arm injection site; This spontaneous case was reported by a consumer and describes the occurrence of SKIN MASS (bump just a size of a quarter/bump has now grown to 3-4 inches in diameter), PYREXIA (temperature is 99.9 Fahrenheit  today), VACCINATION SITE ERYTHEMA (slight reddish round bump on the left arm injection site), ARTHRALGIA (moderate left shoulder joint pain) and VACCINATION SITE SWELLING (has swelling) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     Concurrent medical conditions included Factor V Leiden mutation.    On 10-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Aug-2021, the patient experienced VACCINATION SITE ERYTHEMA (slight reddish round bump on the left arm injection site). On 17-Aug-2021, the patient experienced SKIN MASS (bump just a size of a quarter/bump has now grown to 3-4 inches in diameter), ARTHRALGIA (moderate left shoulder joint pain) and VACCINATION SITE SWELLING (has swelling). On 19-Aug-2021, the patient experienced PYREXIA (temperature is 99.9 Fahrenheit  today). At the time of the report, SKIN MASS (bump just a size of a quarter/bump has now grown to 3-4 inches in diameter), PYREXIA (temperature is 99.9 Fahrenheit  today), VACCINATION SITE ERYTHEMA (slight reddish round bump on the left arm injection site), ARTHRALGIA (moderate left shoulder joint pain) and VACCINATION SITE SWELLING (has swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient taken her last dose of antibiotics for UTI on her vaccination day . Patient takes an anti-coagulant whenever she travels for she had a blood clot on her leg 3 years ago. No treatment details were provided by reporter.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Sluggishness
Clinical narrative: sluggish; 3rd dose without doctor recommendation; This spontaneous case was reported by a consumer and describes the occurrence of SLUGGISHNESS (sluggish) and EXTRA DOSE ADMINISTERED (3rd dose without doctor recommendation) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SLUGGISHNESS (sluggish) and EXTRA DOSE ADMINISTERED (3rd dose without doctor recommendation). At the time of the report, SLUGGISHNESS (sluggish) had not resolved and EXTRA DOSE ADMINISTERED (3rd dose without doctor recommendation) outcome was unknown.            No concomitant medication was reported.  No treatment medication was reported.   This case was linked to MOD-2021-291730 (Patient Link).
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Myalgia, Nasal congestion, Oropharyngeal pain
Clinical narrative: tested positive for covid; Little cough; Body aches; Sore throat; Congestion; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), NASAL CONGESTION (Congestion), COVID-19 (tested positive for covid), COUGH (Little cough) and MYALGIA (Body aches) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006D21A) for COVID-19 vaccination.     Concurrent medical conditions included Depression and Mood disorder. Concomitant products included BUPROPION for Antidepressant therapy, LAMOTRIGINE for Mood disorder.    On 23-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Aug-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat), NASAL CONGESTION (Congestion), COUGH (Little cough) and MYALGIA (Body aches). On 13-Aug-2021, the patient experienced COVID-19 (tested positive for covid). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) for Adverse event, at an unspecified dose and frequency. At the time of the report, OROPHARYNGEAL PAIN (Sore throat), NASAL CONGESTION (Congestion), COVID-19 (tested positive for covid), COUGH (Little cough) and MYALGIA (Body aches) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Aug-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded but is unlikely as the events are more likely related to the event of COVID-19.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: tested positive for covid; Little cough; Body aches; Sore throat; Congestion; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), NASAL CONGESTION (Congestion), COVID-19 (tested positive for covid), COUGH (Little cough) and MYALGIA (Body aches) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006D21A) for COVID-19 vaccination.     Concurrent medical conditions included Depression and Mood disorder. Concomitant products included BUPROPION for Antidepressant therapy, LAMOTRIGINE for Mood disorder.    On 23-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Aug-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat), NASAL CONGESTION (Congestion), COUGH (Little cough) and MYALGIA (Body aches). On 13-Aug-2021, the patient experienced COVID-19 (tested positive for covid). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) for Adverse event, at an unspecified dose and frequency. At the time of the report, OROPHARYNGEAL PAIN (Sore throat), NASAL CONGESTION (Congestion), COVID-19 (tested positive for covid), COUGH (Little cough) and MYALGIA (Body aches) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Aug-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded but is unlikely as the events are more likely related to the event of COVID-19.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tired) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 044A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (tired). At the time of the report, FATIGUE (tired) outcome was unknown.            No concomitant medication were provided by the reporter.  No treatment medication were provided by the reporter.   This case was linked to MOD-2021-291719 (Patient Link).
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Dental discomfort, Hyperaesthesia teeth, Oral discomfort, Pain in extremity
Clinical narrative: felt something strange in the teeth,like it was loose; felt some malaise in the mouth,felt a lot the food in his mouth; he regained the sensitivity there; pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of DENTAL DISCOMFORT (felt something strange in the teeth,like it was loose), ORAL DISCOMFORT (felt some malaise in the mouth,felt a lot the food in his mouth), HYPERAESTHESIA TEETH (he regained the sensitivity there) and PAIN IN EXTREMITY (pain in arm) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027C21A and 027C21A) for COVID-19 vaccination.     The patient's past medical history included Tumor excision (About 10 years ago he had an operation where he lost part of the face and has metal instead because of a tumor he had; so he had no sensibility in that part).   On 15-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Jun-2021, the patient experienced DENTAL DISCOMFORT (felt something strange in the teeth,like it was loose), ORAL DISCOMFORT (felt some malaise in the mouth,felt a lot the food in his mouth), HYPERAESTHESIA TEETH (he regained the sensitivity there) and PAIN IN EXTREMITY (pain in arm). On 17-Jun-2021, DENTAL DISCOMFORT (felt something strange in the teeth,like it was loose) and ORAL DISCOMFORT (felt some malaise in the mouth,felt a lot the food in his mouth) had resolved. At the time of the report, HYPERAESTHESIA TEETH (he regained the sensitivity there) and PAIN IN EXTREMITY (pain in arm) outcome was unknown.            No concomitant medications were reported  No treatment information was reported
Sex: U
Vaccine: COVID19
Symptoms: Chills, Pyrexia, Vomiting
Clinical narrative: Chills; Low fever; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (Low fever) and VOMITING (Vomiting) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Aug-2021, the patient experienced CHILLS (Chills), PYREXIA (Low fever) and VOMITING (Vomiting). At the time of the report, CHILLS (Chills), PYREXIA (Low fever) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication were not reported.  Treatment medication were not reported.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Myocardial infarction
Clinical narrative: Heart attack; This spontaneous case was reported by a consumer and describes the occurrence of MYOCARDIAL INFARCTION (Heart attack) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN CALCIUM (STATIN [ATORVASTATIN CALCIUM]) for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, the patient experienced MYOCARDIAL INFARCTION (Heart attack) (seriousness criteria death and medically significant). The patient died on 14-Mar-2021. The reported cause of death was Heart attack. An autopsy was not performed.            Treatment information was not provided.  Company comment Very limited information regarding this event/s has been provided at this time.  Further information has been requested   Most recent FOLLOW-UP information incorporated above includes: On 20-Aug-2021: Follow-up received and contains reporter contact information.; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested; Reported Cause(s) of Death: Heart attack
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: I have a fever of 40 degrees C after second dose of Moderna; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (I have a fever of 40 degrees C after second dose of Moderna) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (I have a fever of 40 degrees C after second dose of Moderna). At the time of the report, PYREXIA (I have a fever of 40 degrees C after second dose of Moderna) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 40 (High) 40 degrees C.         Concomitant medications were not provided by the reporter. Treatment medications were not provided by reporter.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: She can hold a magnet to her arm and the magnet does not fall off the injection site/Magnet will not move unless she takes does not take it off.; Hurts when she takes magnet off the injection site/Pain stays there for about a half hour; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (She can hold a magnet to her arm and the magnet does not fall off the injection site/Magnet will not move unless she takes does not take it off.) and VACCINATION SITE PAIN (Hurts when she takes magnet off the injection site/Pain stays there for about a half hour) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 027L20A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included ANASTROZOLE (ANASTROL) for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (She can hold a magnet to her arm and the magnet does not fall off the injection site/Magnet will not move unless she takes does not take it off.) and VACCINATION SITE PAIN (Hurts when she takes magnet off the injection site/Pain stays there for about a half hour). At the time of the report, VACCINATION SITE REACTION (She can hold a magnet to her arm and the magnet does not fall off the injection site/Magnet will not move unless she takes does not take it off.) and VACCINATION SITE PAIN (Hurts when she takes magnet off the injection site/Pain stays there for about a half hour) outcome was unknown.      Treatment information was not provided.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy to vaccine, Disturbance in attention, Dizziness, Eyelid irritation, Fatigue
Clinical narrative: Still feels tired; Felt "in and out of it"; Felt like she feels when she has a sulfa allergy/she does have multiple allergies including Sulfa, latex, apples, watermelon, carrots, and other food allergies; Light headed; Couldn't focus; Couldn't keep her eyelids open; Slept for two days straight; This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (Felt like she feels when she has a sulfa allergy/she does have multiple allergies including Sulfa, latex, apples, watermelon, carrots, and other food allergies), DIZZINESS (Light headed), DISTURBANCE IN ATTENTION (Couldn't focus), EYELID IRRITATION (Couldn't keep her eyelids open) and HYPERSOMNIA (Slept for two days straight) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug hypersensitivity (Sulfa), Fruit allergy (Apple), Fruit allergy (watermelon), Vegetable allergy (Carrots), Latex allergy and Food allergy (patient had other food allergies).    On 16-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Aug-2021, the patient experienced ALLERGY TO VACCINE (Felt like she feels when she has a sulfa allergy/she does have multiple allergies including Sulfa, latex, apples, watermelon, carrots, and other food allergies), DIZZINESS (Light headed), DISTURBANCE IN ATTENTION (Couldn't focus), EYELID IRRITATION (Couldn't keep her eyelids open) and HYPERSOMNIA (Slept for two days straight). On 17-Aug-2021, the patient experienced VACCINATION COMPLICATION (Felt "in and out of it"). On 19-Aug-2021, the patient experienced FATIGUE (Still feels tired). On 17-Aug-2021, EYELID IRRITATION (Couldn't keep her eyelids open) and HYPERSOMNIA (Slept for two days straight) had resolved. On 19-Aug-2021, DIZZINESS (Light headed) and DISTURBANCE IN ATTENTION (Couldn't focus) had resolved. At the time of the report, ALLERGY TO VACCINE (Felt like she feels when she has a sulfa allergy/she does have multiple allergies including Sulfa, latex, apples, watermelon, carrots, and other food allergies), VACCINATION COMPLICATION (Felt "in and out of it") and FATIGUE (Still feels tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersomnia, Vaccination complication
Clinical narrative: Still feels tired; Felt "in and out of it"; Felt like she feels when she has a sulfa allergy/she does have multiple allergies including Sulfa, latex, apples, watermelon, carrots, and other food allergies; Light headed; Couldn't focus; Couldn't keep her eyelids open; Slept for two days straight; This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (Felt like she feels when she has a sulfa allergy/she does have multiple allergies including Sulfa, latex, apples, watermelon, carrots, and other food allergies), DIZZINESS (Light headed), DISTURBANCE IN ATTENTION (Couldn't focus), EYELID IRRITATION (Couldn't keep her eyelids open) and HYPERSOMNIA (Slept for two days straight) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug hypersensitivity (Sulfa), Fruit allergy (Apple), Fruit allergy (watermelon), Vegetable allergy (Carrots), Latex allergy and Food allergy (patient had other food allergies).    On 16-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Aug-2021, the patient experienced ALLERGY TO VACCINE (Felt like she feels when she has a sulfa allergy/she does have multiple allergies including Sulfa, latex, apples, watermelon, carrots, and other food allergies), DIZZINESS (Light headed), DISTURBANCE IN ATTENTION (Couldn't focus), EYELID IRRITATION (Couldn't keep her eyelids open) and HYPERSOMNIA (Slept for two days straight). On 17-Aug-2021, the patient experienced VACCINATION COMPLICATION (Felt "in and out of it"). On 19-Aug-2021, the patient experienced FATIGUE (Still feels tired). On 17-Aug-2021, EYELID IRRITATION (Couldn't keep her eyelids open) and HYPERSOMNIA (Slept for two days straight) had resolved. On 19-Aug-2021, DIZZINESS (Light headed) and DISTURBANCE IN ATTENTION (Couldn't focus) had resolved. At the time of the report, ALLERGY TO VACCINE (Felt like she feels when she has a sulfa allergy/she does have multiple allergies including Sulfa, latex, apples, watermelon, carrots, and other food allergies), VACCINATION COMPLICATION (Felt "in and out of it") and FATIGUE (Still feels tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Saw online lots of people have had COVID arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Saw online lots of people have had COVID arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Saw online lots of people have had COVID arm). At the time of the report, VACCINATION COMPLICATION (Saw online lots of people have had COVID arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The treatment medication was not reported.  The concomitant medication was not reported.   This case was linked to MOD-2021-291127, MOD-2021-290851 (Patient Link).
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, COVID-19, Cough, Fatigue, Headache
Clinical narrative: Cough; want to take a nap; runny nose; headache; COVID-19; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19), COUGH (Cough), SOMNOLENCE (want to take a nap), RHINORRHOEA (runny nose) and HEADACHE (headache) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Cough (Had cough for year and half and didn't think much of it.). Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) and ROSUVASTATIN for an unknown indication.    On 24-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Aug-2021, the patient experienced FATIGUE (Fatigue). On 15-Aug-2021, the patient experienced COVID-19 (COVID-19). On an unknown date, the patient experienced COUGH (Cough), SOMNOLENCE (want to take a nap), RHINORRHOEA (runny nose) and HEADACHE (headache). At the time of the report, COVID-19 (COVID-19), COUGH (Cough), SOMNOLENCE (want to take a nap), RHINORRHOEA (runny nose), HEADACHE (headache) and FATIGUE (Fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Aug-2021, SARS-CoV-1 test: negative (Negative) Negative. On 15-Aug-2021, SARS-CoV-1 test: positive (Positive) Positive. On an unknown date, Body temperature: normal (normal) 99.6 degrees Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient mentioned that her pulse ox was 97 at the lowest and also states that her symptoms are mild. No treatment medications were provided.   This case was linked to MOD-2021-132775 (Patient Link).
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-1 test, Somnolence
Clinical narrative: Cough; want to take a nap; runny nose; headache; COVID-19; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19), COUGH (Cough), SOMNOLENCE (want to take a nap), RHINORRHOEA (runny nose) and HEADACHE (headache) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Cough (Had cough for year and half and didn't think much of it.). Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) and ROSUVASTATIN for an unknown indication.    On 24-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Aug-2021, the patient experienced FATIGUE (Fatigue). On 15-Aug-2021, the patient experienced COVID-19 (COVID-19). On an unknown date, the patient experienced COUGH (Cough), SOMNOLENCE (want to take a nap), RHINORRHOEA (runny nose) and HEADACHE (headache). At the time of the report, COVID-19 (COVID-19), COUGH (Cough), SOMNOLENCE (want to take a nap), RHINORRHOEA (runny nose), HEADACHE (headache) and FATIGUE (Fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Aug-2021, SARS-CoV-1 test: negative (Negative) Negative. On 15-Aug-2021, SARS-CoV-1 test: positive (Positive) Positive. On an unknown date, Body temperature: normal (normal) 99.6 degrees Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient mentioned that her pulse ox was 97 at the lowest and also states that her symptoms are mild. No treatment medications were provided.   This case was linked to MOD-2021-132775 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: severe reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (severe reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (severe reaction). At the time of the report, VACCINATION COMPLICATION (severe reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. no treatment medication was provided.   Reporter did not allow further contact
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Product dose omission issue, Rash, Vaccination site erythema
Clinical narrative: real big red hard ball in the injection site; decided not to get second dose; Redness in the injection site; Soreness and muscle ache; headache; rash; This spontaneous case was reported by a non-health professional and describes the occurrence of VACCINATION SITE MASS (real big red hard ball in the injection site), PRODUCT DOSE OMISSION ISSUE (decided not to get second dose), VACCINATION SITE ERYTHEMA (Redness in the injection site), MYALGIA (Soreness and muscle ache) and HEADACHE (headache) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included VITAMINS NOS and PROBIOTICS NOS for an unknown indication.    In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced VACCINATION SITE MASS (real big red hard ball in the injection site), PRODUCT DOSE OMISSION ISSUE (decided not to get second dose), VACCINATION SITE ERYTHEMA (Redness in the injection site), MYALGIA (Soreness and muscle ache), HEADACHE (headache) and RASH (rash). At the time of the report, VACCINATION SITE MASS (real big red hard ball in the injection site), PRODUCT DOSE OMISSION ISSUE (decided not to get second dose), VACCINATION SITE ERYTHEMA (Redness in the injection site), MYALGIA (Soreness and muscle ache), HEADACHE (headache) and RASH (rash) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications are provided.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site mass
Clinical narrative: real big red hard ball in the injection site; decided not to get second dose; Redness in the injection site; Soreness and muscle ache; headache; rash; This spontaneous case was reported by a non-health professional and describes the occurrence of VACCINATION SITE MASS (real big red hard ball in the injection site), PRODUCT DOSE OMISSION ISSUE (decided not to get second dose), VACCINATION SITE ERYTHEMA (Redness in the injection site), MYALGIA (Soreness and muscle ache) and HEADACHE (headache) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included VITAMINS NOS and PROBIOTICS NOS for an unknown indication.    In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced VACCINATION SITE MASS (real big red hard ball in the injection site), PRODUCT DOSE OMISSION ISSUE (decided not to get second dose), VACCINATION SITE ERYTHEMA (Redness in the injection site), MYALGIA (Soreness and muscle ache), HEADACHE (headache) and RASH (rash). At the time of the report, VACCINATION SITE MASS (real big red hard ball in the injection site), PRODUCT DOSE OMISSION ISSUE (decided not to get second dose), VACCINATION SITE ERYTHEMA (Redness in the injection site), MYALGIA (Soreness and muscle ache), HEADACHE (headache) and RASH (rash) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications are provided.
Sex: U
Vaccine: COVID19
Symptoms: Myalgia, Swelling, Vaccination site bruising
Clinical narrative: sore and swollen again; welts around the injection site; Initial soreness wore off; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (sore and swollen again), VACCINATION SITE BRUISING (welts around the injection site) and MYALGIA (Initial soreness wore off) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING (sore and swollen again), VACCINATION SITE BRUISING (welts around the injection site) and MYALGIA (Initial soreness wore off). At the time of the report, SWELLING (sore and swollen again), VACCINATION SITE BRUISING (welts around the injection site) and MYALGIA (Initial soreness wore off) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications was not provided by the reporter. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Myalgia
Clinical narrative: sore; chills; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore) and CHILLS (chills) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (sore) and CHILLS (chills). At the time of the report, MYALGIA (sore) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.